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Neuronal chloride concentration ([Cl−]i) is known to be dynamically modulated and
alterations in Cl− homeostasis may occur in the brain at physiological and pathological
conditions, being also likely involved in glioma-related seizures. However, the mechanism
leading to changes in neuronal [Cl−]i during glioma invasion are still unclear. To characterize
the potential effect of glioma released soluble factors on neuronal [Cl−]i, we used
genetically encoded CFP/YFP-based ratiometric Cl-(apical) Sensor transiently expressed
in cultured hippocampal neurons. Exposition of neurons to glioma conditioned medium
(GCM) caused rapid and transient elevation of [Cl−]i, resulting in the increase of
fluorescence ratio, which was strongly reduced by blockers of ionotropic glutamate
receptors APV and NBQX. Furthermore, in HEK cells expressing GluR1-AMPA receptors,
GCM activated ionic currents with efficacy similar to those caused by glutamate,
supporting the notion that GCM contains glutamate or glutamatergic agonists, which
cause neuronal depolarization, activation of NMDA and AMPA/KA receptors leading to
elevation of [Cl−]i. Chromatographic analysis of the GCM showed that it contained several
aminoacids, including glutamate, whose release from glioma cells did not occur via the
most common glial mechanisms of transport, or in response to hypoosmotic stress.
GCM also contained glycine, whose action contrasted the glutamate effect. Indeed,
strychnine application significantly increased GCM-induced depolarization and [Cl−]i rise.
GCM-evoked [Cl−]i elevation was not inhibited by antagonists of Cl− transporters and
significantly reduced in the presence of anion channels blocker NPPB, suggesting that
Cl− selective channels are a major route for GCM-induced Cl− influx. Altogether, these
data show that glioma released aminoacids may dynamically alter Cl− equilibrium in
surrounding neurons, deeply interfering with their inhibitory balance, likely leading to
physiological and pathological consequences.
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INTRODUCTION
In the central nervous system (CNS), a tight regulation of intra-
cellular chloride concentration ([Cl−]i) is important for a num-
ber of cellular functions, including the stabilization of resting
membrane potential, the regulation of both intracellular pH and
Abbreviations: ACM, Astrocyte conditioned medium; APV, D-2-amino-5-
phosphonopentanoic; [Cl−]i, chloride concentration; CNS, central nervous
system; DMEM, Dulbecco’s Modified Eagle Medium; DMSO, Dimethyl sul-
foxide; EAATs, Excitatory aminoacid transporters; FBS, Fetal Bovine Serum;
FFA, flufenamic acid; GABA, γ-aminobutyric acid; GCM, glioma conditioned
medium; Glu, glutamate; GluR1-HEK cells, HEK 293 stably expressing the
rat flip variant of wild-type glutamate receptor 1; HBSS, Hank’s balanced
salt solution; HPLC, High Performance Liquid Chromatography; HyperGCM,
hyperosmotic glioma conditioned medium; NBQX, 2,3-dihydroxy-6-nitro-7-
sulfamoyl-benzo[f]quinoxaline-2,3-dione; NES, normal external solution; NFA,
niflumic acid; NPPB, 5-Nitro-2-(3-phenylpropylamino)benzoic acid; OPA, o-
phthaldialdehyde; SAS, Sulfasalazine; TBOA, DL-threo-β-Benzyloxyaspartic acid;
TTX, Tetrodotoxin.
cell-volume (Pasantes-Morales et al., 2006; Suzuki et al., 2006)
and the strength and polarity of γ-aminobutyric acid (GABA) and
glycine-mediated neurotransmission (Payne et al., 2003).
Several different pathways allow Cl− movements across neu-
ronal membranes, determining Cl− equilibrium. Among these
are the ligand-gated anion channels (GABAA and glycine recep-
tors), the cation-chloride cotransporters (KCC2 andNKCC1) and
a variety of Cl− channels, including Ca2+-, volume-, and voltage-
activated Cl− channels (Payne et al., 2003; Suzuki et al., 2006;
Jentsch, 2008; Deisz et al., 2011).
Neuronal Cl− equilibrium is subject to alterations both in
physiological and pathological conditions (Staley et al., 1995;
Planells-Cases and Jentsch, 2009; Doyon et al., 2011) and abnor-
mal Cl− homeostasis is associated with neuronal trauma or
brain disorders (De Koninck, 2007). Particularly, in epilepsy,
the alteration of Cl− homeostasis is a widespread phenomenon,
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contributing to neuronal hyperexcitability (Palma et al., 2006;
Barmashenko et al., 2011; Conti et al., 2011). The reported
changes in neuronal Cl− equilibrium affect the inhibitory power
of GABA/glycine, causing its switching to excitatory action. In
addition, neuronal transmembrane Cl− gradient may be altered
by glutamatergic stimulation, through the activation of anionic
channels or changes in Cl− transporters activity (Van Damme
et al., 2003; Slemmer et al., 2004; Kitamura et al., 2008). In the
brain, a similar condition may occur in case of excessive glu-
tamate release, under intense synaptic activity (Fiumelli et al.,
2005; Fiumelli and Woodin, 2007) or reduced glutamate uptake
by astrocytes (Danbolt, 2001). Indeed, even modest increases in
extracellular glutamate concentration can alter synaptic trans-
mission (Araque et al., 1999) and reduced activity of glial glu-
tamate transporters has been suggested to contribute to and
exacerbate a number of neurological conditions, including stroke,
epilepsy, cerebral ischaemia, amyotrophic lateral sclerosis, and
others (O’Shea, 2002).
A dysfunction in glutamate transport has also been reported
in malignant gliomas (Ye et al., 1999). The comparison of glu-
tamate transport into astrocytes vs. their malignant counterparts
showed that gliomas behave opposite to astrocytes, releasing glu-
tamate rather than sequestering it (Ye and Sontheimer, 1999).
Moreover, when glioma cells were co-cultured with neurons, the
released glutamate activated neuronal NMDA receptors, resulting
in excitotoxic cell death, suggesting that the release of excito-
toxic concentrations of glutamate may promote tumor expansion
(Sontheimer, 2003). In addition, glutamate, as well as other
aminoacids (GABA, glycine, serine) may be released, in the brain,
by various cell types during volume changes (Pasantes-Morales
et al., 2006), occurring upon cell migration, edema, or during
glioma cell invasion (Ordaz et al., 2004; Pasantes-Morales and
Vázquez-Juárez, 2012).
In this study we analyzed how glutamate or other aminoacids,
released by glioma cells cause an alteration of Cl− homeostasis.
Taking advantage of a genetically encoded CFP/YFP-based ratio-
metric chloride sensor (Cl-Sensor) (Markova et al., 2008; Waseem
et al., 2010), we investigated how neuronal [Cl−]i is dynamically
regulated by diffusible factors released by cultured glioma cells.
We report that glutamate released from glioma cells triggers
neuronal Cl− rise through the activation of ionotropic glutamate
receptors, cell depolarization and activation of anionic chan-
nels. Such mechanism may partially explain how glioma invasion
causes local dynamic Cl− changes and neuronal Cl− equilibrium
dysfunction.
MATERIALS AND METHODS
ANIMALS
Animal procedures were conducted in accordance with the inter-
national guidelines on the ethical use of animals from the
European Communities Council Directive of 24 November 1986
(86/609/EEC). C57BL/6 (Charles River Laboratory) of either sex
was used.
CELL CULTURES
The glioblastoma patient derived cell line MZC (M.Z.C., kindly
provided by Dr. Antonietta Arcella, Neuromed, Italy, Sciaccaluga
et al., 2010) was grown in Dulbecco’s Modified Eagle Medium
(DMEM, GIBCO) supplemented with 10% heat-inactivated Fetal
Bovine Serum (FBS), 100 IU/ml penicillinG and 100μg/ml strep-
tomycin at 37◦C in a 5% CO2 humidified atmosphere. Medium
was changed twice a week and the cells were sub-cultivated when
confluent and used between 20th and 40th passage when they had
reached 80% confluence.
Primary hippocampal neuronal cultures were obtained from
postnatal day 0–2 (P0-P2) C57BL/6 mice. Briefly, after care-
ful dissection from diencephalic structures, the meninges
were removed under a dissection microscope and the hip-
pocampi were collected in ice-cold Hank’s balanced salt solu-
tion (HBSS, GIBCO Invitrogen) and chopped and digested
in 1.25mg/ml trypsin for 15min at 37◦C. Subsequently, cells
were mechanically dissociated and plated at a density of 105
in poly-L-lysine coated round glass coverslips (12mm diame-
ter) put into 24-well culture plates in serum-free Neurobasal
medium, supplemented with 2% B27, 0.5mM L-Glutamine
and 100μg/ml gentamicin (culture medium). Finally, cells
were kept at 37◦C in 5% CO2 for 10–12 days with a
twice a week medium replacement (1:1 ratio). With this
method we obtained 60–70% neurons, 30–35% astrocytes, and
4–5% microglia, as determined with β-tubulin III, glial fib-
rillary acidic protein, and isolectin IB4 staining (Lauro et al.,
2010).
Primary cortical glial cells were prepared from P0–P2 -old
mice. Cerebral cortices were chopped and digested in 30U/ml
papain for 40min at 37◦C followed by gentle trituration. The
dissociated cells were washed, suspended in DMEM with 10%
FBS (Invitrogen) and 2mm l-glutamine and plated at a den-
sity of 9–10 × 105 in 175 cm2 cell culture flasks. At confluence
(10–14 DIV), glial cells were shaken for 2 h at 37◦C to remove
microglial cells. These procedures gave almost pure astrocytes
cell population (4–6% of microglia contamination), as verified
by staining with glial fibrillary acidic protein and isolectin IB4
(Rosito et al., 2012). Astrocytes were re-plated and used for
experiments.
The human retroviral packaging cell line HEK 293 stably
expressing the rat flip variant of wild-type glutamate recep-
tor 1 (GluR1-HEK cells) was grown in DMEM with geneticin
(0.5mg/ml), Glutamax-I/10% FBS 1% penicillin/streptomycin,
5% CO2 (37◦C). Cells were plated onto 12mm round coverslips
at a density of 104 cells/cm2.
GLIOMA CONDITIONEDMEDIUM (GCM)
Confluent MZC cultures were incubated for 4 h with 10ml of fil-
tered normal external solution (NES) containing (in mM): 140
NaCl, 2.8 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES-NaOH, and 10 glu-
cose (pH 7.32; 300 ± 5 mOsm). This GCM was then centrifuged,
pH adjusted to 7.32 and used for the experiments. The hyperos-
motic glioma conditioned medium (HyperGCM) was obtained
by incubating glioma cells with the following external solutions
in (mM): NaCl 159.6, KCl 3.2, MgCl2 2.28, CaCl2 2.28, HEPES-
NaOH 11.4, glucose 11.4 (114% concentrated NES); or NaCl
154, KCl 2.8, MgCl2 2, CaCl2 2, HEPES-NaOH 10, glucose 25.
Both solutions, adjusted at pH 7.32, were isoosmotic compared
to DMEM (340 ± 10mOsm).
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HIPPOCAMPAL CULTURES TRANSFECTION
Twenty Four hours before transfection, 50% of the neuronal
growth medium was replaced with fresh culture medium.
For transfection 100μl of MEM was mixed with 2μl of
Magnetofection NeuroMag (OZ Bioscience, France) and 1μg
of the cDNA of Cl-Sensor (Markova et al., 2008). The mix-
ture was incubated for 15–20min at room temperature and
thereafter distributed dropwise over the neuronal culture. Cells
were then placed on a magnetic plate (OZ Bioscience) and
incubated for 15min at 37◦C. Transfection was terminated by
substitution of 50% of incubation solution with the fresh cul-
ture medium. Cells were used for the experiments 24–76 h after
transfection.
FLUORESCENCE DETERMINATIONS
Fluorescence images were acquired at room temperature
(22–24◦C) using a customized digital imaging microscope.
Excitation of cells at various wavelengths was achieved using a
1-nm-bandwidth polychromatic light selector (Till Polychrome
V) equipped with a 150W xenon lamp (Till Photonics,
Germany). For the use of Cl-Sensor the optic system is equipped
with an excitation filter D480/30x, an emission filter D535/40m
and a dichroic mirror 500DRLP (500 nm) (Omega Optics,
USA); for the use of FURA-2AM we used a conventional set
of filters (SP410, 510/40m; 400DCLP 400 nm; Omega Optics,
USA). Fluorescence was visualized using an upright microscope
(Axioskope) equipped with a 40 × water-immersion objective
(Achroplan CarlZeiss, USA) and a digital 12 bit CCD camera sys-
tem (SensiCam, PCO AG, Germany); images were acquired on
a computer via a double-coaxial cable. All peripheral hardware
control, image acquisition and image processing were achieved
using customized software TillVision v. 4.0 (Till Photonics,
Germany).
Cells expressing Cl-Sensor were excited alternatively at 445
and 485 nm wavelengths (50ms, 0.1Hz). [Cl−]i changes are
expressed as a ratio of background subtracted F445 over F485
(R = F445/F485). Before starting all the experiments, we evaluated
the basal Cl− level in each neuron, through the emission spec-
trum (for methods see Markova et al., 2008; Bregestovski et al.,
2009). Cells whose shape of emission spectrum corresponded to
high [Cl−]i, were not considered.
The Ca2+ sensitive indicator Fura-2 was used to monitor
changes in the intracellular calcium level in hippocampal neu-
rons. Cells (10–12 DIV) were loaded by adding cell permeant ace-
toxymethyl (AM) derivatives dye (4μM) and incubating dishes
at 37◦C for 45min. Fura-2AM loaded cells were excited alterna-
tively with dual wavelengths of 340 and 380 nm (20ms; 0.2Hz).
Intracellular Ca2+ changes are expressed as a ratio between flu-
orescence emitted after excitation at 340 nm (F340) and after
excitation at 380 nm (F380) [Fluorescence Ratio (R) = F340/F380].
PATCH-CLAMP RECORDINGS
Whole-cell patch-clamp recordings were performed using a
Axopatch 200A amplifier, Digidata 1440 digitizer, on a PC run-
ning pCLAMP software (all from Molecular Devices, Foster
city, CA). Data were acquired at 10 kHz and filtered at 2 kHz.
Patch electrodes were prepared from borosilicate glass using a
vertical electrode puller (PC10, Narishige, Japan) to produce
tip openings of 1–2μm (4–6M). Electrodes were filled with
an intracellular solution containing (in mM): 135 CsMetSO4,
2 MgCl2, 2 MgATP, 0.3 NaGTP, 10 HEPES, 0.5 EGTA; pH
7.3 with CsOH. Recording were performed in normal extra-
cellular solution containing (in mM): 140 NaCl, 2.5 KCl,
2 CaCl2, 2 MgCl2, 10 HEPES–NaOH, and 10 glucose (pH
7.3 adjusted with NaOH, osmolarity 300mOsm). In voltage-
clamp mode of recording cells were held at −70mV; in
current-clamp experiments, the voltage was recorded while cells
were injected with holding current (30–230) pA. Glutamate
concentration–current curves were constructed by applying to
each HEK-AMPA cell (held at −50mV) four or five differ-
ent concentrations of agonist (0.01–1mM) at 60–120 s inter-
vals, in the presence of 25μM cyclothiazide, to prevent GluR1
receptor desensitization (Fucile et al., 2006), and normalizing
the current response to the plateau value, tested in all cells
(corresponding to 1mM). For each cell, the concentration-
current curve was best-fitted using Origin 7 (OriginLab Corp.,
Northampton, MA, USA) to the Hill equation: Inorm = 1/(1 +
ECnH50 /[Glutamate]
nH) where Inorm is the normalized current
response, EC50 is the agonist concentration yielding half-
maximal current response and nH is the Hill coefficient. These
curves were averaged and used to calculate the mean EC50 for
glutamate.
EXPERIMENTAL PROCEDURES AND DRUGS APPLICATION
During fluorescence or electrophysiological measurements, cells
were continuously superfused with external solution, using a
gravity driven perfusion system, positioned 50–100μm from
the cell. Unless otherwise indicated, all experiments were con-
ducted in normal extracellular solution. Concentration response
curves in HEK-AMPA cells were performed with a com-
puter controlled fast perfusion system (Warner Instruments,
USA). Tetrodotoxin (TTX, 1μM) was routinely dissolved
in the extracellular medium. Low Cl− medium contained:
147.5mM Na-Gluconate, 2.8mM K-Gluconate, 2mM MgCl2,
2mM CaCl2, 10mM Glucose, and 10mM HEPES-NaOH
(pH 7.32; 300 ± 5 mOsm). The fluorescence signal was moni-
tored online and stable baseline responses were recorded for at
least 4min before applying drugs. Tetrodotoxin citrate (TTX),
D-2-amino-5-phosphonopentanoic (D-APV), 2,3-dihydroxy-6-
nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX), glu-
tamate, GABA, strychnine hydrochloride, and bicuculline
methochloride were purchased from Abcam (UK). 5-Nitro-2-
(3-phenylpropylamino)benzoic acid (NPPB) and DL-threo-β-
Benzyloxyaspartic acid (TBOA) were purchased from Tocris
(UK). All other drugs used were purchased from Sigma-Aldrich,
Milan, Italy.
NPPB, Sulfasalazine (SAS), and TBOA were dissolved in
Dimethyl sulfoxide (DMSO) and used at 1/1000 dilution and
the same concentration of solvent was used in control condi-
tion. Unless otherwise indicated, AP5, NBQX, and strychnine
were applied to the cells only in co-application with GCM. The
duration of NPPB pretreatment (3–4min) was set to allow sta-
bilization of fluorescence ratio after the change induced by drug
application.
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CHROMATOGRAPHIC ANALYSIS
Aminoacids were determined in supernatants by reversed-phase
High Performance Liquid Chromatography (HPLC) following
o-phthaldialdehyde (OPA) derivatization in the presence of
2-mercaptoethanol. 100μL of samples or standards were mixed
1:1 (v/v) with freshly prepared OPA/2-mercaptoethanol derivatiz-
ing solution (3,5mg of OPA in 50μL of 95% ethanol, diluted with
5mL of borate buffer, pH 10.4, plus 10μL of 2-mercaptoethanol,
protected from light) and injected within 1min onto the col-
umn (Hirschberger et al., 1985). The HPLC consisted of a Waters
apparatus equipped with a 600 pump and pump controller, a
Rheodyne injection valve with a 50μL loop, a Nova-Pack C18
column (reverse phase, 3.9 × 150mm, 4μm particle size, ther-
mostated at 41◦C with a 10mm guard column of the same
material matrix) and a Shimadzu RF-551 fluorometric detec-
tor, operating at λex 360 nm and λem 455 nm. The elution was
performed at a flow rate of 1mL/min, with solvent A being
25mM phosphate buffer, pH 7.0, containing 3% THF, and sol-
vent B 25mM phosphate buffer, pH 7.0, containing 40% CH3CN
and 3% THF. The mobile phase was run isocratically at 5% B
for the first 5min, then solvent B linearly increased to 27% in
10min, remained for 20min at 27% B and finally increased lin-
early to 100% in 1min. At 40min, buffer B was returned to 5%
and the column was allowed to equilibrate for 10min. Total run
time was 50min per sample. Peak identification was performed
on the basis of the retention time and by spiking the sample
with appropriate standards, whereas aminoacid quantitation was
performed by automatic peak area integration using dedicated
software (Millennium32,Waters). Results are expressed asμmoles
of aminoacid per L of sample.
DATA ANALYSIS AND STATISTICS
Data are analyzed with Clampfit 10 (Molecular Devices)
Statistical significance (p < 0.05) was determined using
the paired or unpaired Student’s t-test (Origin software;
Microcal Software, Northampton, MA). Data are reported as
means±standard error of the mean (SEM) and “n” values
refers to the number of neurons examined. All studies involved
different culture sets. Each set of experiments presented was
internally controlled, using similar numbers of control coverslips
to compare with each experimental condition.
RESULTS
GCM EVOKES RAPID AND REVERSIBLE INCREASE IN [CL−]I VIA A
GLUTAMATERGICMECHANISM IN CULTURED HIPPOCAMPAL
NEURONS
In order to assess whether substances released from glioma cells
may alter neuronal chloride homeostasis, we used a CFP/YFP-
based ratiometric Cl-Sensor expressed in primary hippocampal
neuronal cultures (Figure 1A). A glioma conditioned medium
(GCM), prepared exposing cultured MZC glioma cells to NES,
was applied to neurons transfected with Cl-Sensor and changes
in fluorescence ratio (R), associated to [Cl−]i variations, were
monitored over time.
Results indicate that GCM applied for 1min onto neu-
rons expressing Cl-Sensor evokes a rapid and reproducible
increase in fluorescence ratio (R) from 0.63 ± 0.02 to 0.94 ± 0.04
FIGURE 1 | Glioma conditioned medium evokes a transient increase in
[Cl−]i in hippocampal cultured neurons. (A) Visualization of [Cl−]i
increase induced by GCM in hippocampal neurons expressing Cl-Sensor.
(B) Time course of fluorescence ratio increase induced by the exposure of
hippocampal neurons transfected with Cl-Sensor to GCM (1min; n = 108).
(C) Relationship between the amplitude and the duration of [Cl− ]i transients
in hippocampal neurons; each point represents a single determination of
peak amplitude (R) and time of half decay (t/2) of GCM effect.
(R = 0.32 ± 0.03, n = 153, p < 0.01), indicating a strong rise
in [Cl−]i (Figure 1B). R increase was followed by a slow recov-
ery of basal fluorescence, with an average half decay time (t/2) of
3.5 ± 0.3min (n = 123). As shown in Figure 1C, the duration of
t/2 increased with peak amplitude of response to GCM.
Since glioma cells may release glutamate in the extracellular
space (Ye and Sontheimer, 1999; Buckingham et al., 2011) we
wondered whether GCM-induced neuronal [Cl−]i rise could be
triggered by the activation of ionotropic glutamate receptors on
neurons (see Slemmer et al., 2004). To address this issue, we
treated hippocampal neurons with NMDA and AMPA receptors
antagonists (APV 20μM; NBQX 10μM; 3min), before exposing
them to GCM. As shown in Figure 2A, APV and NBQX strongly
reduced GCM-induced responses, giving an average decrease of
R by 81 ± 8% of control (n = 5, p < 0.01), indicating that
GCM leads to a rapid increase of [Cl−]i, by a glutamatergic
mechanism. Consistently, the exposure of Cl-Sensor express-
ing neurons to glutamate (100μM) for 1min evoked a rapid
and reversible increase in R from 0.56 ± 0.02 to 1.01 ± 0.09
(R = 0.45 ± 0.08, n = 28, p < 0.01), similar to that induced by
the application of GCM (Figure 2B). It has been reported that
glutamate can cause changes both in [Cl−]i and [pH]i in neurons
(Wang et al., 1994; Metzger et al., 2002) and Cl-Sensor is known
to be sensitive to pH (Markova et al., 2008). Thus, we monitored
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FIGURE 2 | Glutamatergic mechanism GCM-evoked [Cl−]i increase. (A)
Effect of ionotropic glutamate receptors antagonists on GCM-evoked [Cl−]i
increase. Left, fluorescence trace from an example neuron showing the
effect of application of GCM alone and in the presence of APV (20μM) and
NBQX (10μM). Right, bar chart represents the average of fluorescence
response elicited by GCM in the presence of APV (20μM) and NBQX (10μM)
expressed as the % of control (n = 5 neurons). (B) Time course of the effect
of 100μM glutamate on the fluorescence ratio in Cl-Sensor transfected
hippocampal neurons (n = 28). (C) Fluorescence response to glutamate in
control and in gluconate-based low Cl− medium (8mM); Left, fluorescence
trace from an example neuron showing the effect of application of glutamate
(100μM) in control and in gluconate-based low Cl− medium (8mM).
Right, bar chart represents the average of fluorescence response elicited by
glutamate in the absence of external Cl− expressed as the % of control
(n = 6 neurons). (D) Concentration-current response curve for glutamate
obtained in HEK-AMPA cells (filled squares, ; n = 12). Empty circle (◦)
represents the average amplitude of the current evoked by GCM application
in the same cells, indicative of a glutamate concentration in GCM of
20 ± 2μM. (n = 6). Inset, typical whole-cell currents evoked by glutamate
(10-30-100μM, left) and GCM (right) on HEK-AMPA cells (A–D), horizontal
bars represents drugs application as indicated. Data are shown as mean
values ± SEM. ∗∗p < 0.01.
fluorescence response to glutamate in control and in gluconate-
based low Cl− medium (8mM, similar to the one measured in
Cl-Sensor expressing neurons), to exclude that the fluorescence
transients could depend on the effect of intracellular acidification
on Cl-Sensor properties. The removal of external Cl− abolished
R increase in response to glutamate (R = 0.03 ± 0.01, n = 6,
p < 0.05), suggesting that, in our experimental conditions, the
glutamate-induced fluorescence ratio increase truly represents
[Cl−]i rise (Figure 2C).
Then, in order to functionally evaluate the concentration of
glutamate present in GCM, we constructed a concentration-
current response curve for glutamate in HEK cell lines stably
expressing the GluR1 subunit of AMPA receptors (HEK-AMPA
cells) (Fucile et al., 2000), using five different glutamate con-
centrations and applying GCM on the same cell. Best fits of
concentration-current response curves were averaged and the
mean EC50 for glutamate was 59.4 ± 0.6 μM (nH = 1.30 ± 0.01,
n = 24). The amplitude of currents evoked by GCM application
in the same cells were fitted in the curve, indicating a glutamate
concentration of 20 ± 2μM (Figure 2D n = 6). Consistently,
the application of 20μM glutamate to neurons transfected with
Cl-Sensor was sufficient to cause a transient increase in [Cl−]i
(R = 0.06 ± 0.01, n = 3; not shown).
Altogether, these data suggest that glutamate released from
glioma cells triggers neuronal Cl− rise through the activation of
ionotropic glutamate receptors.
GLIOMA CONDITIONEDMEDIUM CONTAINS EXCITATORYAND
INHIBITORY AMINOACIDS
We used the High-Performance Liquid Chromatography (HPLC)
to quantify the amount of glutamate contained in GCM and
identify other aminoacids eventually present. Figure 3A shows
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FIGURE 3 | GCM contains excitatory and inhibitory aminoacids.
(A) Representative chromatogram of aminoacids present in glioma
conditioned mediums: Asp, aspartate; Glu, glutamate; Ser, serine; Gly,
glycine; Ala, alanine; Tau, taurine; HPLC conditions are described in the
text. (B) Effects of glutamate transport antagonists on GCM glutamate
release. Histogram represents the average of four experiments where
GCM was prepared in the presence of SAS (250mM) or TBOA (100mM).
Glutamate concentration is expressed in % of [glu] in parallel control GCM.
(C) Effect of osmotic stress on aminoacids release from MZC cells.
Histogram represents the concentration of identified aminoacids present in
GCM prepared from hyperosmotic (empty columns; n = 5) or control NES
(filled columns; n = 10). ∗∗p < 0.01.
a representative chromatogram of the aminoacids contained in
GCM. The HPLC analysis confirmed that glioma cells release
a significant amount of glutamate, in addition to several other
aminoacids in the micromolar range, including alanine, aspar-
tate, serine, and glycine (Behrens et al., 2000). Table 1 summarizes
the concentration of the aminoacids present in the GCM. Among
these aminoacids, we highlighted both excitatory (glutamate,
aspartate, glycine, serine) and inhibitory (glycine, taurine) neu-
roactive compounds. In particular, glutamate seems to be the
most relevant excitatory neurotransmitter, with an average con-
centration in GCM of 10.6 ± 1.7μM (n = 11). On the other
hand, among inhibitory neurotransmitters, glycine is by far the
most representative, as its concentration in GCM is appreciably
above the level of taurine or GABA, the latter being undetectable.
Since under specific/pathological circumstances, astro-
cytes may also release glutamate, (Malarkey and Parpura,
2008), we performed HPLC analysis on astrocytes-conditioned
medium, observing an extremely low concentration of glutamate
Table 1 | Concentration of identified aminoacids in glioma and
astrocyte-conditioned medium; table summarizes the concentration
of aminoacids determined in GCM (n = 11) and astrocyte conditioned
medium (ACM) (n = 4) expressed in µM.
AA Concentration in Concentration in
GCM (µM) ACM (µM)
Aspartate 2.3±0.3 6.7± 4.1
Glutamate 10.6±1.7 1.5± 0.9
Serine 8.5±1.4 31.6± 10.1
Glycine 16.0±2.7 22.3± 6.0
Alanine 51.7±7.2 32.0± 4.0
Taurine 1.0±0.5 4.5± 1.4
Glutamate was not quantifiable in 3/3 astrocyte conditioned medium tested;
Alanine was detected only in 1/3 astrocyte conditioned medium at 32 μM.
(1.5 ± 0.9μM, n = 4) in respect to GCM. These data indicate
that, in our experimental conditions, glutamate release is a
specific feature of glioma cells.
Trying to identify the mechanism of glutamate release from
glioma cells, we first put attention to the Xc transport sys-
tem (Buckingham et al., 2011), analyzing the GCM obtained
in the presence of the Xc system blocker sulfasalazine (SAS,
250μM, 4 h). As shown in Figure 3B, SAS treatment did not
reduce the amount of glutamate released in the GCM (94 ± 10%
of control; n = 4). We further tried to interfere with glutamate
release from glioma cells, by blocking glutamate transporters with
the competitive, non-transportable excitatory aminoacid trans-
porters (EAATs) blocker β-threo-benzyloxy aspartate (TBOA,
Shimamoto et al., 1998). However, GCM prepared in the pres-
ence of TBOA (100μM), showed an increased glutamate level
(148 ± 16%, p = 0.01; n = 4), indicating that inMZC cells EAAT
transport is not necessary for glutamate release and rising the sug-
gestion that it may be involved in glutamate uptake (Takano et al.,
2001).
Another possible way of glutamate release is linked to
osmotic stress (Takano et al., 2005). Since the extracellular solu-
tion used for the preparation of GCM, is hypotonic (NES,
300 ± 5mOsm) compared to glioma culture medium (340 ±
10mOsm; DMEM), glutamate could be released in response
to an osmotic stress. Indeed, it has been reported that sev-
eral aminoacids are released from neuronal and non-neuronal
cells in response to hypotonic stress (Ordaz et al., 2004; Takano
et al., 2005; Pasantes-Morales and Vázquez-Juárez, 2012). In par-
ticular, glial cells are able to respond to hypoosmotic swelling,
with a regulatory volume decrease, through the efflux of chlo-
ride, glutamate, and other anions (Kimelberg et al., 1995;
Pasantes-Morales and Vázquez-Juárez, 2012). To test this pos-
sibility, we analyzed the level of glutamate in the GCM, pre-
pared with a hyperosmotic solution (HyperGCM), having the
same osmolarity of the glioma culture medium (∼340 mOsm).
The concentration of glutamate determined in the HyperGCM
by HPLC analysis was 12.5 ± 2.7μM (Figure 3C; n = 5), sim-
ilar to that measured in the GCM, suggesting that the osmotic
stress is not involved in glutamate release. The same holds
for all the identified aminoacids (with the exception of taurine),
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whose concentrations were similar in the two conditions
(Figure 3C).
Altogether, these data indicate that glioma cells release both
excitatory and inhibitory neuroactive compounds. Among them,
glutamate is released, independently of the most conventional
release mechanisms, from glioma cells but not from astrocytes.
GLYCINE RECEPTORS ACTIVATION REDUCES [Cl−]i INCREASE BY
COUNTERACTING GCM-INDUCED NEURONAL DEPOLARIZATION
Since GCM contains a high concentration of glycine, we hypothe-
sized that GCM-induced Cl− influx, may partially occur through
Cl− permeable glycine receptors (GlyR). To test this possibil-
ity, we applied GCM to hippocampal neurons together with the
GlyR antagonist strychnine (1μM). Contrary to what expected,
we observed an enhancement of GCM-induced [Cl−]i rise from a
control value of R = 0.30 ± 0.07 to R = 0.53 ± 0.12 (n = 9;
p = 0.05, Figure 4A). Furthermore, GCM-induced responses in
strychnine were completely abolished in the presence of APV
andNBQX (R = 0.03 ± 0.01, n = 5). Similar experiments, per-
formed in the presence of gabazine (10μM), excluded a contribu-
tion by GABARs, as no significant changes in R were osbserved
(0.37 ± 0.05 in control vs. 0.35 ± 0.08 in gabazine, n = 7; not
shown). These data indicate that when GlyRs are blocked, GCM
evokes a stronger increase of neuronal [Cl−], entirely dependent
on the activation of glutamate receptors.
To investigate whether GCM-induced increase of [Cl−]i
depended on a change in membrane potential, we exposed
cell cultures to GCM during current clamp recordings. GCM
application (10–15 s) caused the depolarization of the mem-
brane potential of about 11.4 ± 3.5mV (n = 27, Figure 4B),
which was absent in the presence of APV and NBQX (n = 4;
not shown). Conversely, when applied together with strych-
nine, GCM-induced a significantly higher depolarization (33.0 ±
4.7mV, p < 0.01; n = 20; Figure 3B). Thus, the activation of
GlyRs, by glycine released from glioma cells, contrasts GCM-
induced neuronal depolarization and this effect is abolished
when GlyRs are blocked by strychnine. Consistently, in Cl-Sensor
expressing neurons, the reversal potential for chloride was slightly
more negative (–73± 2mV) than the resting membrane potential
(–66± 4mV), as estimated by gramicidin-based perforated patch
clamp recordings (n = 6, not shown), indicating that the activa-
tion of GlyRs likely induces neuronal hyperpolarization. Again,
GCM-induced depolarization in strychnine was abolished by
APV and NBQX (2.0 ± 0.9mV, n = 7, Figure 4B), demonstrat-
ing that it is entirely dependent on the activation of ionotropic
glutamate receptors.
Moreover, when neuronal depolarization was induced by the
application of high K+ (20mM, 1min) an increase in [Cl−]i
rise was induced with a R of 0.29 ± 0.07 (n = 18, p < 0.01;
Figure 4C), supporting the hypothesis that depolarization is the
key event for Cl− entrance into neurons.
ANIONIC CHANNELS AND CATIONIC CHLORIDE TRANSPORTERS ARE
INVOLVED IN GCM-INDUCED Cl− FLUXES
Neuronal depolarization may favor Cl− entry simply augment-
ing Cl− driving force, or also activating pathways of chloride
flux, which are closed at resting potential. Thus we, used a
pharmacological approach trying to shed light on the involve-
ment of Cl− channels and transporters in GCM effects. To inves-
tigate the role of transporters in GCM-induced Cl− influx, we
exposed hippocampal neurons to the cation chloride transporters
blocker furosemide (100μM). In the presence of this compound,
FIGURE 4 | Glycine receptors activation reduces GCM-induced [Cl−]i
increase by counteracting neuronal depolarization. (A) Effect of
(1μM) strychnine on GCM-evoked [Cl− ]i increase. Left, representative
fluorescence trace from a single transfected neuron, monitored during
the application of GCM alone, in the presence of strychnine (1μM) and
in the presence of strychnine plus APV (20μM) and NBQX (10μM).
Right, histogram representing the average R increase induced by GCM in
GCM alone and in the presence of strychnine (n = 9) and in strychnine
plus APV/NBQX (n = 6). (B) Strychnine increases GCM-induced
depolarization in hippocampal neurons in current clamp recordings. Left,
sample trace from an hippocampal neuron recorded in current clamp
during the application of GCM as in (A) Note remarkable increase in
depolarization in the presence of strychnine. Right, columns represent
the depolarization induced by GCM, alone (n = 11) or in the presence of
strychnine (n = 5). (C) Time course of R increase induced by the
application of a modified external medium containing high KCl (20mM,
1min; n = 18, ). ∗p < 0.05; ∗∗p < 0.01.
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the application of GCM-evoked a transient increase in [Cl−]i in
average not dissimilar in respect to control (R = 0.49 ± 0.12 vs.
0.66 ± 0.14; n = 9; p = 0.4, paired t-test; Figure 5A). However,
in most of the experiments, the amplitude of R increase was
reduced or increased by furosemide, suggesting that both KCC2
and NKCC1 could be involved in GCM-induced Cl− flux. In fact
furosemide blocks both transporters, which are expressed in cul-
tured hippocampal neurons. We sought to discriminate between
the potentially opposite roles of these two Cl− transporters, by
using specific antagonists DIOA and bumetanide.
To block KCC2, we incubated Cl-Sensor expressing hippocam-
pal cultures in the presence of DIOA (20μM; 2 h), perform-
ing experiments in the continuous presence of the drug. In
these conditions GCM application still induced an increase of
R, which resulted of R = 0.30 ± 0.11 (n = 10) compared to
slightly higher controls (0.55 ± 0.19, n = 8, p = 0.25, indepen-
dent t-test). However, as shown in Figure 5B, Cl− did not
recover to basal level after GCM washout, indicating that KCC2,
although not required for GCM-induced Cl− entry, is necessary
for reestablishing Cl− equilibrium. In addition, the basal R in
cells treated with DIOA was higher than control, indicating that
prolonged block of KKC2 leads to accumulation of basal Cl−
in neurons (see also Pellegrino et al., 2011). Conversely, when
we exposed neurons to GCM in the presence of bumetanide,
to block NKCC1, we observed an increase in the amplitude of
R transients from a control R of 0.48 ± 0.13 to 0.81 ± 0.18
(n = 8; p = 0.03; Figure 5C). This augmented Cl− influx is likely
due to the block of NKCC1-mediated rapid Cl− extrusion by
reverse transport during intracellular Cl− load (Brumback and
Staley, 2008). The block of NKCC1 did not alter the slow recov-
ery after GCM application, indicating that, in our experimental
conditions, this transporter is not necessary as KCC2 for the
recovery of normal Cl− equilibrium. In addition, the applica-
tion of bumetanide did not cause significant changes in the basal
fluorescence ratio. All together, these data indicate that cation
chloride transporters do not play a key role in GCM-induced Cl−
entry but their activity may modulate the amount of Cl− entry
likely affecting the speed of recovery or changing the driving force
of Cl− flux.
It is known that glutamate may lead to neuronal Cl− influx
through the activation of different classes of anionic channels
(Backus et al., 1998; VanDamme et al., 2003; Slemmer et al., 2004;
Inoue and Okada, 2007). Thus, to find out whether anionic chan-
nels contributed to GCM-induced neuronal Cl− influx, we tested
FIGURE 5 | Cl− channels and transporters are involved in
GCM-induced Cl− transients. (A) Effect of furosemide on the peak
amplitude of GCM-induce transients (n = 9; p = 0.4, paired t-test). (B)
Time course of R increase induced by GCM in neurons treated with
DIOA (n = 9, ◦) and untreated control neurons (n = 7, ). (C) Left,
example trace representing the effect of acute application of bumetanide
on GCM-induced Cl− transient; right, histogram representing the average
effect of bumetanide on GCM-induced ratio increase. (D) Example trace
of the effect of NPPB (40μM) on GCM-induced R increase; inset, trace
with extended time scale representing GCM application in NPPB.
(E) Effect of NPPB 100μM; trace and inset as in (D). (F) Histogram
representing the effect of anionic channels blockers on GCM-induced R
increase in hippocampal neurons. NPPB 40μM (n = 4) and 100μM
(n = 5); NFA (100μM; n = 3); FFA (200μM; n = 5). All data are
expressed as the percentage of the control GCM response in the same
cells. ∗p < 0.05; ∗∗p < 0.01.
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the effect of the broad spectrum anion channels blocker 5-Nitro-
2-(3-phenylpropylamino) benzoic acid (NPPB, 40–100μM).
NPPB, which is known to block a Cl-driven outwardly rec-
tifying current in neurons (Van Damme et al., 2003), dose
dependently reduced GCM-induced increase in [Cl−]i. At 40μM
it caused a reduction of R to 66 ± 10% of control (n = 4,
p < 0.05; Figures 5D,F) and at 100μM to 31 ± 6% of control
(n = 9; p < 0.01; Figures 5E,F), indicating that NPPB-sensitive
anion channels largely contribute to GCM-induced Cl− entry in
hippocampal neurons. In addition, in the presence of 100μM
NPPB cells were unable to recover [Cl−]i to basal level after
GCM application or neuronal Cl− load. This suggests that anionic
channels are involved in GCM-induced Cl− entry, as well as, its
recovery. NPPB also caused, by itself, an increase in the basal flu-
orescence ratio (see Figures 5D,E), likely due to Cl− influx, as it
was absent when the drug was applied in low external Cl− (8mM;
n = 3, not shown).
It has been reported a slight reduction effect of NPPB on
AMPA-mediated currents (Van Damme et al., 2003). To ascertain
the specificity of its effect the on Cl− flux, we checked whether this
drug could affect the glutamate-induced depolarization in cur-
rent clamp recordings. Glutamate similarly depolarized neurons
in control and in the presence of NPPB, respectively, to −10.0 ±
2.2 and to −13.6 ± 6.3mV (n = 5, P = 0.5). However, NPPB
itself caused a significant depolarization of the neuronal mem-
brane potential of 10.2 ± 2.4mV (n = 8, not shown) which could
be the cause of NPPB-induced Cl− influx and of the delayed
recovery of basal Cl− level.
To further analyze the involvement of anionic channels, we
tested the effect of two other anionic channels blockers niflu-
mic acid (NFA) and flufenamic acid (FFA) on GCM response
(Figure 5F). NFA (100μM) reduced the GCM-induced Cl−
transient to 77 ± 6% of control (n = 3; p = 0.06), while FFA
(200μM) was uneffective (107 ± 14; n = 5; p = 0.78). NFA,
similarly to NPPB, also delayed recovery of [Cl−]i after GCM-
induced transients (not shown).
Altogether, these data indicate that the application of GCM
mainly determines neuronal [Cl−]i influx, increasing due to
depolarization the driving force for Cl− entry, presumably
through anionic channels. Anionic channels and cation chlo-
ride transporters are also involved in the recovery of [Cl−]i
equilibrium after GCM-induced Cl− load.
DISCUSSION
In the present study, we characterized the effect of neuroactive
aminoacids released by glioma cells on neuronal [Cl−]i, taking
advantage of a genetically encoded CFP/YFP-based ratiomet-
ric Cl-Sensor (Markova et al., 2008; Bregestovski et al., 2009;
Waseem et al., 2010), which was transiently expressed in cul-
tured hippocampal neurons. We observed that acute applica-
tion of GCM causes a rapid [Cl−]ì increase in neurons via
glutamatergic mechanism, mimicked by the application of glu-
tamate and largely dependent on NPPB-sensitive anionic chan-
nels. Moreover, HPLC and electrophysiological analysis showed
that GCM contains a functionally relevant amount of glutamate
and other neuroactive aminoacids, including aspartate, glycine,
and serine. Glycine, released by glioma cells, counteracts the
mechanisms triggered by glutamate, likely contrasting neuronal
depolarization.
To date, there is little knowledge available on the mechanisms
regulating homeostasis of Cl− in either physiological or patho-
logical conditions, especially for the technical difficulties in the
measurement of Cl− fluxes. In this paper, we used Cl-Sensor, a
probe with a high sensitivity to Cl− (EC50 ∼30mM), that has
been demonstrated to be an effective tool for the quantitative
estimation of [Cl−] in various cellular compartments (Markova
et al., 2008; Bregestovski et al., 2009; Waseem et al., 2010).
In our study, several lines of evidence support the notion that
GCM alters neuronal Cl− equilibrium, causing glutamatergic-
mediated Cl− infux in hippocampal neurons: (i) GCM-induced
fluorescence increase is abolished in the presence of antagonists
of ionotropic glutamatergic receptors; (ii) exogenously applied
glutamate evokes similar [Cl−]i rise; and (iii) CGM contains glu-
tamatergic agonists at functionally relevant concentration. The
ability of glutamate to cause elevation of intracellular [Cl−] has
been already shown in physiological (Van Damme et al., 2003;
Slemmer et al., 2004; Kitamura et al., 2008) and pathological con-
texts (Inoue and Okada, 2007; Wang and Qin, 2012). Particularly
relevant to our study is that excitotoxic stimulation of gluta-
mate receptors may also lead to pH changes (Wang et al., 1994),
since Cl-Sensor properties might be influenced by acidification
(Markova et al., 2008). However, in our experimental conditions,
fluorescence ratio increases reasonably represent [Cl−]i accumu-
lation, because the response evoked by application of glutamate
disappeared when we strongly decreased Cl− driving force, low-
ering external [Cl−] to 8mM. Consistently, Waseem et al. (2010)
and Pellegrino et al. (2011) illustrated the transient glutamate-
induced increase of [Cl−]i, in spinal neurons and hippocampal
neurons transfected with Cl-Sensor.
HPLC analysis on GCM confirmed that MZC cells, exposed
to control external medium, release a relevant concentration of
glutamate, together with other neuroactive aminoacids, giving
results very consistent with those found in microdialysis exper-
iments from glioma and peritumoral space in implanted rats
(Behrens et al., 2000). In chromatographic analysis we focused
on aminoacids commonly involved in signaling mechanisms,
although some of them still need to be ascertained (see Behrens
et al., 2000). Apparently, themechanism of glutamate release from
glioma cells is different from themost common ways of glutamate
transport or release, being insensitive to Xc system or EAATs inhi-
bition. This is not surprising since Xc system contribution should
be limited in the absence of extracellular cystine and EAATs activ-
ity is controversial in glioma cell lines (Ye et al., 1999; Buckingham
et al., 2011). Our data with TBOA suggest that EAAT transport
system is functional inMZC cells, likely participating in glutamate
uptake. Although glutamate release fromMZC cells is not evoked
by osmotic stress, as described in glial cells, we cannot exclude
a contribution of anionic channels, possibly activated by other
means (Takano et al., 2005). However, the mechanism of gluta-
mate release by MZC cells needs further investigation. Indeed,
other typical ways of astrocytic glutamate release, as P2X7 ATP-
gated channels, gap junction hemichannels, or vescicular release
(Malarkey and Parpura, 2008), could be functional in glioma
cell cultures (see Samadani et al., 2007). Notably, the observed
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glutamate release is a specific feature of glioma cells, being glu-
tamate concentration detected in astrocyte conditioned medium,
extremely low in comparison to GCM. It should be considered,
alternatively, that the observed difference in glutamate concen-
tration might depend on a more functional astrocytic glutamate
uptake rather than on different release properties (Takano et al.,
2001).
Indeed, the HPLC results showed that GCM contained rele-
vant concentrations of other aminoacids including glycine, serine,
and aspartate and might in various ways interfere with neuronal
activity. It is known that aminoacids may be released by glial cells
both for osmotic (Ordaz et al., 2004) and signaling functions, sev-
eral of them being already identified as putative gliotransmitter
(Behrens et al., 2000; Cavallero et al., 2009). However, some of
these substances might have a specific action during glioma inva-
sion and the circumstances of release from glioma cells deserve
further investigation.
Our results show that GlyR activation interferes with the depo-
larizing effect of GCM. The Cl− influx through GlyRs may act
as a shunting mechanism that counteracts the glutamate-induced
depolarization of the membrane potential. Depolarization is
likely the key event in GCM-induced Cl− influx, as previously
proposed for glutamate effects (Backus et al., 1998; Van Damme
et al., 2003; Slemmer et al., 2004) and confirmed here by the
ability of K+ to induce a Cl− rise similar to that observed with
glutamate or GCM. It could be discussed that in the presence
of strychnine, GCM-induced Cl− accumulation is abolished by
GluR antagonists, while a residual Cl− transient is observed when
GlyRs are not blocked. These results could indicate a participa-
tion of GlyRs to Cl− influx, particularly in cells with depolarized
resting potential.
Cation chloride transporters have a minor role in GCM
induced Cl− flux, being mainly involved in restoration of Cl−
equilibrium after GCM stimulation. The potentiating effect of
bumetanide is likely due to the block of NKCC1-mediated rapid
Cl− extrusion by reverse transport during intracellular Cl− load
(Brumback and Staley, 2008). Alternatively, it is possible to spec-
ulate that bumetanide effect on GCM-induced Cl− influx, might
reflect an increase in Cl− driving force, caused by bumetanide
mediated decrease in [Cl−]i, (Chabwine et al., 2009). However,
this possibility is not supported by our observations.
On the other hand, we show that the depolarization-induced
Cl− influx involves NPPB-sensitive anionic channels and a sig-
nificant increase of the neuronal driving force for Cl−. The main
concern in the interpretation of our results arises from the lack of
specific pharmacological tools for anionic channels. In fact, many
of the compounds used to block anionic channels are reported to
have unspecific effects and, as shown here, may alter Cl− equi-
librium and membrane potential. However, our data are strongly
consistent with previous reports, showing that anionic channels,
activated by depolarization or swelling, are responsible of neu-
ronal Cl− entry, following glutamate receptor activation (Van
Damme et al., 2003; Slemmer et al., 2004; Inoue and Okada,
2007). We speculate that these may include Ca2+-, volume- and
voltage-activated Cl− channels (Payne et al., 2003; Suzuki et al.,
2006; Jentsch, 2008; Deisz et al., 2011). However, other anion
permeable channels could be involved, including the high con-
ductance hemichannel Pannexin 1 which is expressed in neurons
and is a Cl-permeable and sensitive to NPPB (Ma et al., 2012).
Altogether, our results suggest a mechanism allowing glioma
cells to deeply and dynamically interfere with neuronal Cl−
homeostasis, through the release of excitatory and inhibitory
neuroactive substances. In physiological conditions, a similar
inhibitory shunt of glutamatergic responses by Cl− permeable
ligand-gated channels, might occur in case of GABA and glu-
tamate corelease, as described in hippocampal mossy fibers
(Treviño et al., 2011), or as a consequence of tonic GABA release
(Semyanov et al., 2004). The observed shunt is reminiscent of that
caused by unconventional GABA release (Koch and Magnusson,
2009), i.e., during intense synaptic activity (Glykys and Mody,
2007). Interestingly, the resulting excitation/inhibition balance
can be altered an in epilepsy models, as a results of increased
GABAergic inhibition (Treviño et al., 2011). A possible concern in
the interpretation of our results is represented by the use of neu-
ronal cultures. In the healthy brain, glutamate is rapidly removed
from the extracellular space by astrocytes, preventing extensive or
prolonged activation of neuronal glutamate receptors (Danbolt,
2001) and its action may be contrasted by tonic GABA release
(Semyanov et al., 2004). Although, it is known that during tumor
invasion brainmicroenvironment is altered (Behrens et al., 2000),
the application of GCM might not represent the natural concen-
tration profile experienced by neurons. Further in vivo studies
will be needed to ascertain if the proposed mechanism may sup-
port the alterations of Cl− homeostasis, causing the imbalance of
inhibitory and excitatory neuronal network properties observed
in glioma associated epilepsy.
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